deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT02597153

Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas

A Single-arm, Open, Multi-center Phase II Clinical Trial of Mitoxantrone HCL Liposome Injection in Subjects With Relapsed Cutaneous T Cell Lymphomas

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Conditions Relapsed Cutaneous T Cell Lymphom
Interventions Mitoxantrone HCL Liposome Injection
Updated 6 times since 2017 Last updated: May 23, 2017 Started: Oct 31, 2015 Primary completion: Oct 31, 2017 Completion: Oct 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Just one subject enrolled in this trial during one and a half years.

Other terminated trials from CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

More terminations from CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Listed as NCT02597153, this PHASE2 trial focuses on Relapsed Cutaneous T Cell Lymphom and remains terminated or withdrawn. Sponsored by CSPC ZhongQi Pharmaceutical Technology Co., Ltd., it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshotRecruiting~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Jun 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2017 [monthly]

    Recruiting PHASE2

    First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Data source: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations